Congestive heart failure · people with endocarditis on the left side of the heart (on native or prosthetic valves) with bacteraemia for Streptococcus, Enterococcus…
It is very uncertain whether partial oral treatment changes congestive heart failure compared with conventional intravenous treatment of endocarditis on the left side… (very low certainty).
1 finding from 1 review
Congestive heart failure · people with endocarditis caused by Staphylococcus aureus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for cardiac surgical interventions · people with endocarditis on the left side of the heart (on native or prosthetic valves) with bacteraemia for Streptococcus, Enterococcus…
It is very uncertain whether partial oral treatment changes need for cardiac surgicalinterventions compared with conventional intravenous treatment of endocarditis on the left side… (very low certainty).
1 finding from 1 review
Septic embolism · people with endocarditis on the left side of the heart (on native or prosthetic valves) with bacteraemia for Streptococcus, Enterococcus…
It is very uncertain whether partial oral treatment changes septic embolism compared with conventional intravenous treatment of endocarditis on the left side… (very low certainty).
1 finding from 1 review
Uncontrolled infection · people with endocarditis on the left side of the heart (on native or prosthetic valves) with bacteraemia for Streptococcus, Enterococcus…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Septic embolism4 · people with endocarditis caused by Staphylococcus aureus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for cardiac surgical interventions · people with endocarditis caused by Staphylococcus aureus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Uncontrolled infection4 · people with endocarditis caused by Staphylococcus aureus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality during hospital stay and all‐cause mortality at 1 year · people with endocarditis caused by Staphylococcus aureus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cure · people with endocarditis caused by Staphylococcus aureus
It is very uncertain whether lipopeptide antibiotic (daptomycin) changes cure compared with aminoglycoside (low‐dose gentamicin) plus antistaphylococcal… (very low certainty).
1 finding from 1 review
All‐cause mortality · people at any baseline risk of CVD
Effect of reducing saturated fat showed no clear difference in all‐cause mortality compared with usual saturated fat on CVD risk (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · people at any baseline risk of CVD
Effect of reducing saturated fat showed no clear difference in cardiovascular mortality compared with usual saturated fat on CVD risk (moderate certainty).
1 finding from 1 review
Combined cardiovascular events · people at any baseline risk of CVD
Effect of reducing saturated fat probably leads to lower combined cardiovascular events compared with usual saturated fat on CVD risk (moderate certainty).
1 finding from 1 review
Myocardial infarction · people at any baseline risk of CVD
It is very uncertain whether effect of reducing saturated fat changes myocardial infarctions compared with usual saturated fat on CVD risk (very low certainty).
1 finding from 1 review
Non‐fatal MI · people at any baseline risk of CVD
Effect of reducing saturated fat showed no clear difference in non‐fatal MI compared with usual saturated fat on CVD risk (low certainty).
1 finding from 1 review
Stroke · people at any baseline risk of CVD
It is very uncertain whether effect of reducing saturated fat changes stroke compared with usual saturated fat on CVD risk (very low certainty).
1 finding from 1 review
Coronary heart disease mortality – CHD deaths · people at any baseline risk of CVD
Effect of reducing saturated fat showed no clear difference in CHD mortality compared with usual saturated fat on CVD risk (low certainty).
1 finding from 1 review
CHD events · people at any baseline risk of CVD
It is very uncertain whether effect of reducing saturated fat changes CHD events compared with usual saturated fat on CVD risk (very low certainty).
1 finding from 1 review
CVD · people at high risk of CVD (history of CVD or high LDL‐C despite treatment)
Alirocumab leads to lower CVD compared with placebo (high certainty).
1 finding from 1 review
All‐cause mortality · people at high risk of CVD (history of CVD or high LDL‐C despite treatment)
Alirocumab showed no clear difference in all‐cause mortality compared with ezetimibe and statins (low certainty).
1 finding from 1 review